Client News

InflaRx Announces Strategy Focused on Capital-Efficient Execution with Izicopan and Near-Term Value Creation

Andera Partners co-leads $160 Million Series A round for Alveus to Advance Next-Generation Therapies for Obesity and Metabolic Diseases

VarmX and Rentschler Biopharma partner to advance novel coagulation therapy toward Phase 3 and commercialization

AFYREN confirms drawdown of €7 million in previously secured financing for its subsidiary AFYREN NEOXY

Abivax Provides 2026 Corporate Outlook

Andera Partners Leads $67 Million Series A Financing in Spiro Medical to Develop a Neuromodulation System for Asthma

AL-S Pharma to present at the upcoming J. P. Morgan 2026 Annual Healthcare Conference on Thursday, January 15

EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treatment for Schizophrenia, in Japan

Newron Further Expands Intellectual Property Portfolio for Evenamide with New EU Composition of Matter Patent

Mainz Biomed Provides Review of 2025 Highlights